When Daniel Amos, Aflac’s chairman and chief executive, looked at the shareholder proposals for the US health insurer’s annual meeting two years ago, one item jumped out.
A small shareholder wanted the US health insurer to give investors a vote on executive pay. In his 16 years in charge of the Georgia-based company, Mr Amos had never been faced with such a request.
